Physician profile
Mark Albini
NPI 1518921907
$1,837.75
in general payments reported to CMS, 2019-2025
29 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $902 · 2020: $400 · 2021: $128 · 2022: $27.94 · 2023: $40.38 · 2024: $160 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $379.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $444.44 | 2019-2020 | |
| Avanos Medical | $163.32 | 2019-2020 | |
| Astellas Pharma US INC | $123.60 | 2019-2025 | Veozah |
| Aspira Women'S Health INC | $101.18 | 2024-2025 | Ova1 |
| Bard Access Systems, INC. | $99.70 | 2019 | |
| Avion Pharmaceuticals | $93.25 | 2019-2021 | |
| Exeltis, USA INC. | $87.87 | 2019-2024 | Slynd |
| Therapeuticsmd, INC. | $79.53 | 2019-2021 | |
| Allergan, INC. | $70.33 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $69.63 | 2019-2023 | Gardasil 9 |
| Coopersurgical, INC. | $52.87 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.29 | 2021-2025 | |
| Duchesnay USA Incorporated | $44.49 | 2019 | |
| Mayne Pharma Commercial LLC | $43.50 | 2022-2025 | |
| Millicent US INC | $34.51 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $32.06 | 2019 | |
| Mylan Pharmaceuticals INC. | $29.74 | 2019 | |
| Sage Therapeutics, LLC | $25.76 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $25.43 | 2021 | |
| Exact Sciences Corporation | $19.30 | 2025 | The Cologuard Plus Collection Kit |
| Vertical Pharmaceuticals, LLC | $19.22 | 2019 | |
| Agile Therapeutics, INC. | $18.83 | 2021 | |
| Monaghan Medical Corporation | $16.46 | 2023 | Aerobika |
| Organon LLC | $16.31 | 2024 | |
| Pfizer INC. | $16.05 | 2024 | |
| Amag Pharmaceuticals, INC. | $15.73 | 2019 | |
| Medicem INC. | $15.62 | 2021 | |
| Medtronic, INC. | $14.48 | 2022 | |
| Lupin INC. | $14.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Albini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.